Clinical trial
Inhibition of α-synuclein Cell-cell Transmission by NMDAR Blocker, Memantine
NCT03858270
Study timeline
Study start (actual)2019-04-01Date precision: day
Registry last updated2020-07-01
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Parkinson Diseaseunresolved
Interventions
MemantineDRUG · verified · RxNorm: memantine
PlaceboOTHER
Sponsors & collaborators
Wayne State Universitylead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03858270 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.